Marianna Zahurak, M.S.
Peer-Reviewed Publications
Geller, R.B., Saral, R., Piantadosi, S., Zahurak, M., Vogelsang,
G.B., Wingard, J.R., Ambinder, R.F., Beschorner, W.B., Braine, H.G.,
Burns, W.H., Hess, A.D., Jones, R.J., May, W.S., Rowley, S.D., Wagner,
J.E., Yeager, A.M., and Santos, G.W. Allogeneic Bone Marrow Transplantation
After High-Dose Busulfan and Cyclophosphamide in Patients with Acute
Nonlymphocytic Leukemia. Blood, 73(8):2209-2218, 1989.
Forastiere, A.A., Orringer, M.B., Perez-Tamayo, C., Urba, S.G.,
Husted, S., Takasugi, B.J. and Zahurak, M. Concurrent Chemotherapy
and Radiation Therapy Followed by Transhiatal Esophagectomy for Local-Regional
Cancer of the Esophagus. J. Clin. Oncol. 8(1):119-127, 1990.
Wingard, J.R., Piantadosi, S., Burns, W.H., Zahurak, M.L., Santos,
G.W., and Saral, R. Cytomegalovirus Infections in Patients Treated
by Intensive Cytoreductive Therapy with Marrow Transplant. Reviews
of Infectious Disease, 12(7):S793-S804, 1990.
Geller, R.B., Hurwitz, C.A., Civin, C.I., Zahurak, M., Karp, J.E.,
Datilio, K.L., Piantadosi, S. and Burke, P.J. Characterization and
Prognostic Importance of CD34 (My10)-Positive Acute Myelocytic Leukemia
in Adults. Brit. J. Haematology, 76(3):340-347, 1990.
Ness, P.M., Walsh, P.C., Zahurak, M., Baldwin, M.L., and Piantadosi,
S. Prostate Cancer Recurrence in Radical Surgery Patients Receiving
Autologous or Homologous Blood. Transfusion, 32(1):31-6, 1992.
Wingard, J.R., Plotnick, L.P., Freemer, C.S., Zahurak, M., Piantadosi,
S., Miller, D.F., Vriesendorp, H.M., Yeager, A.M., and Santos, G.W.
Growth in Children after Bone Marrow Transplantation: Busulfan Plus
Cyclophosphamide Versus Cyclophosphamide Plus Total Body Irradiation.
Blood, 79(4):1068‑73, 1992.
Wagner, J.E., Zahurak, M., Piantadosi, S., Geller, R.B., Vogelsang,
G.B., Wingard, J.R., Saral, R., Griffin, G., Shah, N., Zehnbauer,
B.A., Ambinder, R., Burns, W., Jones, R., May, W.S., Rowley, S.,
Yeager, A., and Santos, G.W. Bone Marrow Transplantation of Chronic
Myelogenous Leukemia in Chronic Phase: Evaluation of the Risks and
Benefits. J. Clin. Onc., 10(5):779-789, 1992.
Forastiere, A.A., Orringer, M.B., Perez-Tamayo, C., Urba, S.G. and
Zahurak, M.. Preoperative Chemoradiation Followed by Transhiatal
Esophagectomy for Carcinoma of the Esophagus: Final Report. J. Clin.
Onc., 11(6):1118-1123, 1993.
Goodman, S.N., Zahurak, M.L., and Piantadosi, S. Some Practical
Improvements in 2he Continual Reassessment Method for Phase I Studies.
Statist. Med., 14(11):1149-1161, 1995.
Greenberg, R.S., Maxwell, L.G., Zahurak, M., and Yaster, M. Preanesthetic
Medication of Children with Midazolam Using the Biojector Jet Injector.
Anesthes., 83(2):264-269, 1995.
Koch, W.M., Brennan, J.A., Zahurak, M., Goodman, S.N., Westra, W.H.,
Schwab, D., Yoo, G.H., Lee, D.J., Forastiere, A., and Sidranski,
D. p53 Mutation and Locoregional Treatment Failure in Head and Neck
Squamous Cell Carcinoma. J. Natl. Cancer Inst., 88(21):1580-1586,
1996.
Forastiere, A.A., Heitmiller, R.F., Lee, D-J., Zahurak, M., Abrams,
R., Kleinberg, L., Watkins, S., Yeo, C.J., Lillemoe, K.D., Sitzmann,
J.V., and Sharfman, W. Intensive Chemoradiation Followed by Esophagectomy
for Squamous Cell and Adenocarcinoma of the Esophagus. Cancer J.
Sci. Am., 3(3): 144-152; comments 137-139, 1997.
Yeo, C.J., Cameron, J.L., Sohn, T.A., Lillemoe, K.D., Pitt, H.A.,
Talamini, M.A., Hruban, R.H., Ord, S.E., Sauter, P.K., Coleman, J.,
Zahurak, M.L., Grochow, L.B., and Abrams, R.A. Six Hundred Fifty
Consecutive Pancreaticoduodenectomies in the the 1990s. Ann. Surg., 226(3):248-260,
1997.
Forastiere, A.A., Orringer, M.B., Perez-Tamayo, C., Urba, S.G.,
and Zahurak, M. Preoperative Chemoradiation Followed by Transhiatal
Esophagectomy for Carcinoma of the Esophagus: Final Report. Accepted,
Classic Papers and Current Comments: Highlights of Clinical Gastrointestinal
Cancer Research, 3(2), 1998.
Mikhak, B., Zahurak, M., Abeloff, M.D., Fetting, J.H., Davidson,
N.E., Donehower, R.C., Waterfield, W., and Kennedy, M.J. Long Term
Follow-up of Women Treated with 16-week, Dose-intensive Adjuvant
Chemotherapy for High Risk Breast carcinoma. Cancer, 85(4):
826-833, 1999.
Rashid, A., Zahurak, M., Goodman, S.N. and Hamilton,S.R. Genetic
Epidemiology of Mutated K-Ras Proto-oncogene, Altered Suppressor
Genes and Microsatellite Instability in Colorectal Adenomas. Gut, 44(6):
826-833, 1999.
Ha, P.K., Eisele, D.W., Frassica, F.J., Zahurak, M.L., and McCarthy,
E.F. Osteosarcoma of the Head and Neck: A Review of the Johns Hopkins
Experience. Laryngoscope, 109(6): 964-969, 1999.
Abrams, R.A., Grochow, L.B., Chakravarthy, A., Sohn, T.A., Zahurak, M.L., Haulk, T.L., Ord, S., Hruban, R.H., Lillemoe, K.D., Pitt, H.A.,
Cameron, J.L., Yeo, C.J. Intensified Adjuvant Therapy for Pancreatic
and Periampullary Adenocarcinoma: Survival Results and Observations
Regarding Patterns of Failure, Radiotherapy Dose and CA19-9 Levels.
Int. J. Radiation Oncology Biol. Phys., 44(5): 1039-1046,
1999.
Mignano, J.E., Zahurak, M.L., Chakravarthy, A., Piantadosi, S.,
Dooley, W.C., and Gage, I. Significance of Axillary Lymph Node Extranodal
Soft Tissue Extension and Indications for Postmastectomy Irradiation.
Cancer, 86(7): 1258-1262, 1999.
Keller, J.J., Offerhaus,G.J.A., Polak, M., Goodman, S.N., Zahurak, M.L., Hylind, L.M., Hamilton, S.R., and Giardiello, F.M. Rectal Epithelial
Apoptosis in Familial Adenomatous Polyposis Patients Treated with
Sulindac. Gut, 45(6):822-828, 1999.
Bristow, R.E., Rosenshein, N.B., Grumbine, F.C., Montz, F.J. Stage
IVB Endometrial Carcinoma: the Role of Cytoreductive Surgery and
Determinants of Survival. Gynecol. Oncol., 78:85-91, 2000.
Han, M., Piantadosi, S., Zahurak, M.L., Sokoll, L.J., Chan, D.W.,
Epstein, J.I., Walsh, P.C., and Partin, A.W. Serum and Phosphatase
Level and Biochemical Recurrence following Radical Prostatectomy
for Men with Clinically Localized Prostate Cancer. Urol., 57(4):707-711,
2001.
Bristow, R.E., Duska, L.R., Montz, F.J. The Role of Cytoreductive
Surgery in the Management of Stage Iv Uterine Papillary Serious Carcinoma.
Gynecol. Oncol., 81:92-99, 2001.
Bristow, R.E., and Montz, F.J. Complete Surgical Cytoreduction of
Advanced Ovarian Carcinoma Using the Argon Beam Coagulator. Gynecol.
Oncol., 83:39-48, 2001.
Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz,
R.S., Armstrong, D.K.,
Montz, F.J., Micropapillary Serous Ovarian Carcinoma: Surgical Management
and Clinical Outcome. Gynecol. Onc., 86:163-170, 2002.
Rosty, C., Christa, L., Kuzdal, S., Baldwin, W.M., Zahurak,
M.L.,
Carnot, F., Chan, D.W., Canto, M., Lillemoe, K.D., Cameron, J.L.,
Yeo, C.L., Hurban, R.H., and Goggins, M. Identification of Hepatocarcinoma-intestine-pancreas/pancreatitis-associated
Protein I as a Biomarker for Pancreatic Ductal Adenocarcinoma by
Protein Biochip Technology. Cancer Res., 62(6): 1868-1875,
2002.
Sinibaldi, V.J., Carducci, M.A., Moore-Cooper, S., Laufer, M., Zahurak, M., and Eisenberger, M.A. Phase II Evaluation of Docetaxel Plus One-day
Oral Estramustine Phosphate in the Treatment of Patients with Androgen
Independent Prostate Carcinoma. Cancer, 94(5): 1457-1465,
2002.
Bristow, R.E., Asrari, F., Trimble, E.L.., Montz, F.J. Extended
Surgical Staging for Uterine Papillary Serous Carcinoma: Survival
Outcome for Loco-regional (Stage I-iii Disease). Accepted, Gynecol.
Oncol., 2002.
Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz,
R.S., Armstrong, D.K., Montz, F.J., Recurrent Micropapillary Serous
Ovarian Carcinoma Cancer, 95(4): 791-800, 2002.
Kleinberg, L., Knisely, J., Heitmiller, R. Zahurak, M., Salem, R., Butness, B., Heath, E., Forastiere, A. Mature Survival Results with Preoperative Cisplatin, Protracted Infusion 5-FU, and 44-GY Radiotherapy for Esophageal Cancer. Int J Radiat Oncol Biol Phys., 56(2): 328-334, 2003.
Ghaffar, H., Sahin, F., Sanchez-Cepedes, M., Su, G.H., Zahurak, M., Sidransky, D., and Westra, W.H. LKB1 Protein Expression in the Evolution of Glandular Neoplasia of the Lung. Clin. Cancer Res., 9(8):3058-0064, 2003
Han, M., Partin, A.W., Zahurak, M., Piantadosi, S., Epstein, J.I., and Walsh, P.C. Biochemical (Prostate Specific Antigen) Recurrence Probability following Radical Prostatectomy for Clinically Localized Prostate Cancer. J Urol., 169(2): 517-523, 2003
McCarthy DM, Hruban RH, Argani P, Howe JR, Conlon KC, Brennan MF, Zahurak M, Wilentz RE, Cameron JL, Yeo CJ, Kern SE, Klimstra DS. Role of
the DPC4 Tumor Suppressor Gene in Adenocarcinoma of the Ampulla of Vater: Analysis of 140 Cases. Mod Pathol., 16(3): 272-278, 2003.
Del Carmen, M.G., Smith, Selvdev, A.E., Fader, A.N., Zahurak, M.L., Richardson, M., Fruehauf, J.P., Mont, F.J., and Bristow, R.E. Endometrosis-Associated Ovarian Carcincoma: Differential Expression of Vascular Endothelial Growth Factor and Estrogen/Progesterone Receptors. Cancer, 98(8):1658-1663, 2003.
Bristow, R.E., del Carmen, M., Pannu, H., Cohade, C. Zahurak, M., Fishman, E. Wahl, R., Montz, F.J. Clinically Occult Recurrent Ovarian cancer:Patient Selection for Secondary Cytoreductive Surgery Using, Combined PET/CT. Gynecol. Oncol., 90(3):519-528, 2003.
Ha, P.K., Benoit, N.E., Yochem, R., Scuibba, J., Zahurak, M., Sidransky, D., Pevsner, J., Westra, W.H., Califano, J. A Transcriptional Progression Model for Head and Neck Cancer. Clin. Cancer Res., 9(8):3058-3064, 2003.
Bristow, R.E., Zahurak, M.L., Alexander, C.J., Zellars, R.C., and Montz, F.J. FIGO Stage IIIC Endometrial Carcinoma: Resection of Macroscopic Nodal Disease and other Determinants of Survival. Int. J. Gynecol Cancer, 13:1-9, 2003.
Koopmann, J., Buckhaults, P., Brown, D.A., Zahurak, M.L., Sato, N., Sokoll, L., Chan, D.W., Yeo, C.J., Hruban, R.H., Breit, S.N., Kinzler, K.W., Vogelstein, B.,
and Goggins, M. Serum Macrophage Inhibitory Cytokine 1 as a Marker of Pancreatic andn other Periampullary Cancers. Clin. Ca. Res., 10:2386-2392, 2004.
Yegnasubramanian, S., Gonzalgo, M.L., Kowalski J., Zahurak, M., Piantadosi, S., Walsh, P.C., Bova, S.G., DeMarzo, A.M., Isaacs, W.B., Nelson, W.G. Hypermethylation of CpG islands in Primary and Metastatic Human Prostate Cancer. Ca. Res., 64(6):1975-1986, 2004.
Ho, T., Zahurak, M., and Koch, W.M. Prognostic Significance of Presentation-to-Diagnosis Interval in Patients with Oropharyngeal Carcinoma. Arch. Otolaryngol. Head Neck Surg., 130(1):45-51, 2004.
Bristow, R.E., Zahurak, M.L., del Carmen, M.G., Gordon, T.A., Fox, H.E., Trimble, E.L., and Montz, F.J. Ovarian Cancer Surgery in Maryland: Volume-based Access to care. Gyn. Oncol., 93(2):353-360, 2004.
Eisenberger, M.A., Laufer, M., Vogelzang, N.J., Sartor, O., Thornton, D., Neubauer, B.L., Sinibaldi, V., Lieskovsky, G., Carducci, M.A., Zahurak, M., Raghavan, D.
Phase I and Clinical Pharmacology Of A Type I And II, 5-Alpha-Reductase Inhibitor (LY320236) In Prostate Cancer: Elevation Of Estradiol As Possible Mechanism Of Action. Urol., 63(1):114-119, 2004.
Xin, W., Yun, K.J., Ricci, F., Zahurak, M., Qiu, W., Su, G.H., Yeo, C.J., Hruban, R.H., Kern, S.E., Iacobuzio-Donahue, C.A. MAP2K4/MKK4 Expression in Pancreatic Cancer: Genetic Validation of Immunohistochemistry and Relationship to Disease Course. Clin Cancer Res., 15;10(24):8516-20, 2004.
Kim, M.M, Clinger, J.D., Masayesva,B.G., Ha, P.K., Zahurak, M.L., Westra, W.H., Califano, J.A. Mitochondrial DNA Quantity Increases with Histopathologic Grade in Premalignant and Malignant Head and Neck Lesions. Clin Cancer Res., 10(24):8512-8515, 2004.
Umbricht, C.B., Conrad, G.T., Clark, D.P., Westra, W.H., Smith, D.C., Zahurak, M., Saji, M., Smallridge, R.C., Goodman, S., Zeiger, M.A. Human Telomerase Reverse Transcriptase Gene Expression and the Surgical Management of Suspicious Thyroid Tumors. Clin Cancer Res., 10(17):5762-5768, 2004.
Goldberg, J., Jacobsohn, D.A., Zahurak, M.L., Vogelsang, G.B. Gastrointestinal Toxicity from the Preparative Regimen is Associated with an Increased Risk of Graft-versus-host Disease. Biol Blood Marrow Transplant., 11(2):101-107, 2005.
Simpkins, F., Zahurak, M., Armstrong, D., Grumbine, F., Bristow, R. Ovarian Malignancy in Breast Cancer Patients with an Adnexal Mass. Obstet Gynecol., 105 (3): 507-513, 2005.
Diaz-Montes, T.P., Alberg, A., Zahurak, M.L., Trimble, E.L., Bristow, R.E. Cancer of Uterine Corpus among Hispanic Women Living in the United States: Patterns of Staging, Diagnosis, and Primary Treatment. Gynecol Oncol., 96(3): 753-759, 2005.
Santillan, A., Garge, R., Zahurak, M.L., Gardner, G.J., Giuntoli, R.L. 2nd, Armstrong, D.K., Bristow, R.E. Risk of Epithelial Ovarian Cancer Recurrence in Patients with Rising Serum CA-125 Levels within the Normal Range. J Clin Oncol., 23(36): 9338-9334, 2005.
Rosenbaum, E., Hoque, M.O., Cohen, Y., Zahurak, M., Eisenberger, M.A., Epstein, J.I., Partin, A.W., Sidransky, D. Promoter Hypermethylation as an Independent Prognostic Factor for Relapse in Patients with Prostate Cancer Following Radical Prostatectomy. Clin Cancer Res. 2005; 11(23): 8321-8325.
Diaz-Montes, T.P., Ji, H., Smith, Sehdev, A.E., Zahurak, M.L., Kurman, R.J., Armstrong, D.K., Bristow, R.E. Clinical Significance of Her-2/neu Overexpression in Uterine Serous Carcinoma. Gynecol Oncol., 100(1):139-144, 2005.
Begum, S., Cao, D., Gillison, M., Zahurak, M., Westra, W.H. Tissue Distribution of Human Papillomavirus 16 DNA Integration in Patients with Tonsillar Carcinoma. Clin Cancer Res., 11(16): 5694-6599, 2005.
Diaz-Montes, T.P., Ji, H., Smith, Sehdev, A.E., Zahurak, M.L., Kurman, R.J., Armstrong, D.K., Bristow, R.E. Clinical Significance of Her-2/neu Overexpression in Uterine Serous Carcinoma. Gynecol Oncol., 100(1):139-144, 2005.
Garge R, Zahurak ML, Trimble EL, Armstrong DK, Bristow RE. Abdominal Carcinomatosis in Women with a History of Breast Cancer. Gynecol Oncol., 99(1): 65-70, 2005.
Rosenbaum E, Hosler G, Zahurak M, Cohen Y, Sidransky D, Westra WH. Mutational Activiation of BRAF is not a Major Event in Sporadic Childhood Papillary Thyroid Carcinoma. Mod Pathol., 18(7): 898-902, 2005.
Rosenbaum E, Zahurak M, Sinibaldi V, Carducci MA, Pili R, Laufer M, DeWeese TL, Eisenberger MA. Marimastat in the Treatment of Patients with Biochemically Relapsed Prostate Cancer: a Prospective Randomized, Double-blind, Phase I/II Trial. Clin Cancer Res., 11(12) 4437-4443, 2005.
North RB, LaRocca VR, Schwartz J, North CA, Zahurak M Davis RF, McAfee PC. Surgical Management of Spinal Metastases: Analysis of Prognostic Factors During a 10-Year Experience. J Neurosurg Spine 2(5): 564-573, 2005.
Hustinx SR, Fukushima N, Zahurak ML, Riall TS, Maitra A, Brosens L, Cameron JL, Yeo CJ, Offerhaus GJ, Hruban RH, Goggins M. Expression and Prognostic Significance of 14-3-3sigma and ERM Family Protein Expression in Periampullary Neoplasms. Cancer Biol Ther., 4(5): 596-601, 2005.
Mamelak AJ, Kowalski J, Murphy K, Yadava N, Zahurak M, Kouba DJ, Howell BG, Tzu J, Cummins DL, Liegeois NJ, Berg K, Sauder DN. Downregulation of NDUFA1 and Other Oxidative Phosphorylation-related Genes is a Consisten Feature of Basal Cell Carcinoma. Exp Dermatol., 14(5): 336-348, 2005.
Jiang WW, Masayesva B, Zahurak M, Carvalho AL, Rosenbaum E, Mambo E, Zhou S, Minhas K, Benoit N, Westra WH, Alberg A, Sidransky D, Koch W, Califano J. Increased Mitochondrial DNA Content in Saliva Associated with Head and Neck Cancer. Clin Cancer Res., 11(7):2486-2491, 2005.
Jiang WW, Rosenbaum E, Mambo E, Zahurak M, Masayesva B, Carvalho AL, Zhou S, Westra WH, Alberg AJ, Sidranksy D, Koch W, Califano JA. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res., 12(5):1564-1569, 2006.
Diaz-Montes, T.P., Ji, H., Smith, Sehdev, A.E., Zahurak, M.L., Kurman, R.J., Armstrong, D.K., Bristow, R.E. Clinical Significance of Her-2/neu Overexpression in Uterine Serous Carcinoma. Gynecol Oncol, 100(1):139-144, 2006.
Bristow, R.E., Asrari, F., Trimble, E.L.., Montz, F.J. Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome for Loco-regional (Stage I-iii Disease). Accepted, Gynecol Oncol., 2006.
Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz, R.S., Armstrong, D.K., Montz, F.J. Recurrent Micropapillary Serous Ovarian Carcinoma. The Role of Secondary Cytoreductive Surgery. Accepted, Cancer, 2006.
Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz, R.S., Armstrong, D.K., Montz, F.J. Recurrent Micropapillary Serous Ovarian Carcinoma. The Role of Secondary Cytoreductive Surgery. Accepted, Cancer, 2006.
Friedman, A., Zahurak, M. TEL-AML1, Expressed from t(12;21) in Human Acute Lymphocytic Leukemia, Induces Acute Leukemia in Mice. Accepted, Cancer Res., 2006.
Bristow R., Santillan A., Zahuark M, Gardner GJ, Giuntoli RL, and Armstrong, D.K. Salvage Cytoreductive Surgery for Recurrent Endometrial Cancer. Gynecol Oncol, 103 (1):281-287, 2006.
Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D. Quantitation of Promoter Methylation of Multiple Genes in Urine DNA and Bladder Cancer Detection. JNCI, 98, (14): 996-1004, 2006.
Jiang WW, Zahurak M , Goldenberg D, Milman Y , Park HL, Westra WH, Koch W, Sidransky D, Califano J. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer, Sep 21, 2006 epub
Bristow R, Nugent AC, Zahurak ML, Khouzhami V and Fox HE. Impact of Surgeon Specialty on Ovarian-Conserving Surgery in Young Females with an Adnexal Mass. J Adolesc Health, 39, (3):411-416, 2006.
Sinibaldi VJ, Elza-Brown K, Schmidt J, Eisenberger MA, Rosenbaum E, Denmeade SR, Pili R, Walczak J, Baker SD, Zahurak M, Carducci MA. Phase II Evaluation of Docetaxel Plus Exisulind in Patients With Androgen Independent Prostate Carcinoma. Am J Clin Oncol, 29, (4):395-398.
Díaz-Montes TP, Zahurak ML, Giuntoli II RL, Gardner GJ and Bristow RE. Uterine cancer in Maryland: Impact of surgeon case volume and other prognostic factors on short-term mortality. Gynecol Oncol, July 27, 2006 epub
Alphs HH, Zahurak ML, Bristow RE and Díaz-Montes TP. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol, July 26, 2006 epub
Diaz-Montes TP, Farinola MA, Zahurak ML, Bristow RE, Rosenthal DL. Clinical utility of atypical glandular cells (AGC) classification: Cytohistologic comparison and relationship to HPV results. Gynecol Oncol, 104, (2):366-371, 2007. Epub 2006 Oct 16.
Salani R, Santillan A, Zahurak ML, Giuntoli RL 2nd, Gardner GJ, Armstrong DK, Bristow RE. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.
Cancer, 109, (4):685-691, 2007.
Santillan A, Kim YW, Zahurak ML, Gardner GJ, Giuntoli RL 2nd, Shih IM, Bristow RE. Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma. Int J Gynecol Cancer, 17, (3):601-606, 2007.
Zahurak ML, Parmigiani G, Yu W, Scharpf RB, Berman D, Schaeffer E, Shabbeer S, Cope L. Pre-processing Agilent microarray data. BMC Bioinformatics, (8):142, 2007.
Díaz-Montes TP, Zahurak ML and Bristow RE. Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer. Gynecol Oncol
Díaz-Montes TP, Zahurak ML, Giuntoli II RL and Bristow RE. Concentration of uterine cancer surgical care among the elderly: A population-based perspective. Gynecol Oncol
Nevo S, Fuller AK, Zahurak ML, Hartley E, Borinsky ME, Vogelsang GB. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. Transfusion, 47, (9):1700-1709, 2007.
Jacobsohn D.A., Chen A.R., Zahurak ML, Piantadosi S., Anders V., Bolaños-Meade J., Higman M., Margolis J., Kaup M., Vogelsang G.B. Phase II Study of Pentostatin in Patients With Corticosteroid-Refractory Chronic Graft-Versus-Host Disease, Journal of Clinical Oncology, 25, (27): 4255-4261, 2007.
|
